Disease: Charcot-Marie-Tooth disease- Type 2B
- A Novel HSPB1<sup>S139F</sup> Mouse Model of Charcot-Marie-Tooth Disease
- A novel RAB7 mutation in a Chinese family with Charcot-Marie-Tooth type 2B disease
- Alteration of the late endocytic pathway in Charcot-Marie-Tooth type 2B disease
- Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2B
- An altered lipid metabolism characterizes Charcot-Marie-Tooth type 2B peripheral neuropathy
- Autophagy and Lysosomal Functionality in CMT2B Fibroblasts Carrying the RAB7<sup>K126R</sup> Mutation
- Charcot Marie Tooth 2B Peripheral Sensory Neuropathy: How Rab7 Mutations Impact NGF Signaling?
- Charcot-Marie-Tooth 2b associated Rab7 mutations cause axon growth and guidance defects during vertebrate sensory neuron development
- Charcot-Marie-Tooth 2B mutations in rab7 cause dosage-dependent neurodegeneration due to partial loss of function
- Charcot-Marie-Tooth Type 2B: A New Phenotype Associated with a Novel <em>RAB7A</em> Mutation and Inhibited EGFR Degradation
- Clinical and genetic features of Charcot-Marie-Tooth disease 2F and hereditary motor neuropathy 2B in Japan
- Defective axonal transport of Rab7 GTPase results in dysregulated trophic signaling
- Factors Affecting Phenotype Variability in a Family with CMT2B: Gender and LRSAM1 Genotype
- Fly model causes neurological rethink
- Human Rab7 mutation mimics features of Charcot-Marie-Tooth neuropathy type 2B in Drosophila
- Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies
- Membrane Targeting and GTPase Activity of Rab7 Are Required for Its Ubiquitination by RNF167
- Mitochondria dysfunction in Charcot Marie Tooth 2B Peripheral Sensory Neuropathy
- Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain
- Rab18 Collaborates with Rab7 to Modulate Lysosomal and Autophagy Activities in the Nervous System: an Overlapping Mechanism for Warburg Micro Syndrome and Charcot-Marie-Tooth Neuropathy Type 2B
- Rab7 may be a novel therapeutic target for neurologic diseases as a key regulator in autophagy
- The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy